Table 3.
Patients' haematological parameters for the experimental period. Values are means + S.D.
| Haematological. | Day of Experimental Period | |||||
| Parameter | 0 | 3 | 7 | 14 | 21 | 28 |
| Haemoglobin (g/dl) | ||||||
| Male [17] | .7±1.7 | 12.1±1.4 | 11.7±1.0 | 11.8±0.9 | 2.0±1.1 | 12.5±1.0 |
| Female [14] | 11.8±1.4 | 10.9±1.6 | 10.4±1.6 | 11.0±1.3 | 11.5±1.3 | 11.6±1.6 |
| Haematocrit | ||||||
| Male [17] | 0.38±.05 | 0.37±.03 | 0.36±.0.6 | 0.36±.03 | 0.37±.03 | 0.38±.04 |
| Female [14] | 0.36±.04 | 0.34±.05 | 0.36±.06 | 0.36±.03 | 0.37±.03 | 0.38±.04 |
| ESR (mm/h) | ||||||
| Male [16] | 44.8±30.7 | 56.4±34.1 | 55.8±24.5 | 55.6±33.5 | 51.3±27.3 | 52.9±38.2 |
| Female [13] | 67.2±35.0 | 54.3±38.1 | 92.6±46.0 | 78.2±23.8 | 64.3±30.1 | 56.7±25.9 |
| Total WBC (×109/L) [31] | 7.9±3.7 | 5.4±1.5 | 5.8±1.5 | 6.1±1.7 | 5.9±2.0 | 6.3±1.6 |
| Platelet(× 1010/L0 [31] | 18.7±9.9 | 20.3±18.4 | 27.1±12.9 | 32.2±10.8 | 29.3±11.9 | 26.4±9.1 |
| Reticulocyte (%) [25] | 1.85±.60 | 1.78±.48 | 1.89±56 | 1.80±.49 | 1.70±.36 | 1.84±.35 |